Page 7 - Buzz Show News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “AMC Entertainment Set to Reopen all NYC Theaters”FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “AMC Entertainment Set to Reopen all NYC Theaters” AMC Entertainment (NYSE: AMC) gained just over 7% in premarket trading on news that it will reopen all 13 of its theatres in New York City beginning March 5. The company announced its intentions after New...

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original conten...

#post_contentFinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Novavax Shares Rise After Reporting Phase 3 Clinical Trial Results”

#post_contentFinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Fluidigm Corporation Receives CE-IVD Mark for Its Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19”

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Adamis Pharmaceuticals Skyrockets Amid IND Submission to FDA for Covid-19 Treatment” Adamis Pharmaceuticals (NASDAQ: ADMP) shot up over 27% in premarket trading after announcing the submission of an Investigational New Drug to the FDA for the use of Tempol. It is used as a treatment for COVID-19, Tempol has demonstrated both potent anti-inflammatory, anticoagulant, and antioxidant activity and the submission of the IND follows a Pre-IND meeting with FDA. Adamis Pharmaceuticals Corporation is a specialty bi...